Neurotrypsin activators are compounds that stimulate the activity or increase the expression of neurotrypsin, a serine protease primarily found in the brain. This enzyme plays a crucial role in neural processes, particularly in synaptic plasticity and neuronal morphogenesis. Neurotrypsin is known to process specific neural substrates, and its dysregulation has been linked to certain neurological conditions. The correct balance of neurotrypsin activity is essential for maintaining proper neuronal function and ensuring the health of neural networks.
One interesting aspect of neurotrypsin's function is its association with the GSK3β and the Wnt/β-catenin signaling pathway. Glycogen synthase kinase 3 beta (GSK3β) is a key enzyme in the Wnt/β-catenin pathway, a signaling cascade vital for various cellular processes, including cell fate determination, proliferation, and migration. Wnt signaling leads to the stabilization and accumulation of β-catenin in the cytoplasm, which then translocates to the nucleus to modulate gene expression. Neurotrypsin can influence this pathway by modulating the activity or availability of certain pathway components or by processing proteins that interact with pathway members. The precise mechanism by which neurotrypsin interacts with GSK3β and the broader Wnt/β-catenin pathway remains an area of active research. However, the association underscores the multifaceted roles that neurotrypsin may play in cellular signaling, beyond its direct proteolytic targets. Activators of neurotrypsin, in this context, could have broad implications for the modulation of neural processes and signaling pathways, emphasizing the intricate interplay between proteases and cellular signaling cascades in the neural landscape.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
By inactivating GSK3β and leading to nuclear accumulation of β-catenin and activation of Wnt signaling, Lithium Chloride may indirectly promote Neurotrypsin expression. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $180.00 $610.00 | 4 | |
As a GSK3 inhibitor that activates Wnt/β-catenin signaling, CHIR99021 may create a favorable condition for Neurotrypsin expression. | ||||||
GSK-3 Inhibitor IX | 667463-62-9 | sc-202634 sc-202634A sc-202634B | 1 mg 10 mg 50 mg | $58.00 $188.00 $884.00 | 10 | |
By inhibiting GSK3β and activating Wnt/β-catenin signaling, BIO may promote Neurotrypsin expression. | ||||||
Kenpaullone | 142273-20-9 | sc-200643 sc-200643A sc-200643B sc-200643C | 1 mg 5 mg 10 mg 25 mg | $61.00 $153.00 $231.00 $505.00 | 1 | |
By inhibiting GSK3β, Kenpaullone may activate Wnt/β-catenin signaling, potentially promoting Neurotrypsin expression. | ||||||
GSK-3β Inhibitor VIII | 487021-52-3 | sc-202636 sc-202636A | 5 mg 10 mg | $134.00 $150.00 | 5 | |
As a GSK3β inhibitor, AR-A014418 may activate Wnt/β-catenin signaling, creating a favorable condition for Neurotrypsin expression. | ||||||
GSK-3β Inhibitor I | 327036-89-5 | sc-221692 sc-221692A | 5 mg 25 mg | $183.00 $288.00 | 4 | |
By being a non-ATP competitive GSK3β inhibitor, TDZD-8 has the potential to activate Wnt/β-catenin signaling, promoting Neurotrypsin expression. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $71.00 $202.00 | 18 | |
As a GSK3 inhibitor, SB-216763 may activate Wnt/β-catenin signaling, potentially promoting Neurotrypsin expression. | ||||||
Tideglusib | 865854-05-3 | sc-507358 | 10 mg | $77.00 | ||
Being a non-ATP competitive GSK3β inhibitor, Tideglusib has the potential to activate Wnt/β-catenin signaling, promoting Neurotrypsin expression. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
As an HDAC inhibitor that might also influence GSK3 and Wnt/β-catenin signaling, Valproic Acid may create a favorable condition for Neurotrypsin expression. | ||||||